Search
for

    Did you mean In Vitro Skin Absorption?
    GlossaryIn Vitro Skin Absorption

    study of substance penetration through skin in lab settings

    In Vitro Skin Absorption refers to the process of studying how substances penetrate the skin using laboratory techniques outside of a living organism. This method involves applying a substance to a skin sample, often from human or animal sources, and measuring how much of the substance passes through the skin layers. It is commonly used in research and product development to assess the safety and efficacy of topical medications, cosmetics, and other skin-applied products.

    Related Terms

    Learn

    5 / 57 results

      learn Valproic acid

      an anticonvulsant repurposed for hair loss via histone inhibition

      learn Exosomes

      Microscopic delivery system that sends growth-promoting signals to hair follicles

      learn Caffeine

      the stimulant you know and love can be used topically to stimulate hair

      learn KY19382

      compound that activates Wnt/β-catenin to promote hair regrowth and create new hair follicles

      learn Procyanidin

      bioflavonoid found in plants with antioxidant and hair stimulating properties

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Looks like a real cure to the root of baldness (DHT-induced senescence) was proven earlier this year

      in Research/Science  739 upvotes 2 years ago
      A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermal papilla cells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 2 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.